THC Therapeutics, Inc.
THC Therapeutics, Inc. THCT Peers
See (THCT) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| THCT | $0.00 | -0.00% | 12068.00 | -0.01 | -$0.02 | N/A |
| MKGAF | $144.55 | +4.90% | 62.85B | 20.02 | $7.22 | +1.55% |
| MKKGY | $27.71 | -2.33% | 59.68B | 19.24 | $1.44 | +1.36% |
| HLNCF | $5.10 | +3.04% | 46.01B | 24.29 | $0.21 | +2.10% |
| TKPHF | $26.30 | -9.00% | 41.39B | 29.22 | $0.90 | +5.06% |
| IPSEY | $28.48 | +0.07% | 37.69B | 23.73 | $1.20 | +1.11% |
| SDZNY | $45.05 | +0.30% | 19.40B | -2252.25 | -$0.02 | +0.91% |
| TEVJF | $16.11 | -11.73% | 18.46B | -14.01 | -$1.15 | N/A |
| ESALY | $61.51 | -2.11% | 17.64B | 20.54 | $3.00 | N/A |
| SGIOY | $8.49 | +2.41% | 14.44B | 12.48 | $0.68 | +0.95% |
Stock Comparison
THCT vs MKGAF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, MKGAF has a market cap of 62.85B. Regarding current trading prices, THCT is priced at $0.00, while MKGAF trades at $144.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas MKGAF's P/E ratio is 20.02. In terms of profitability, THCT's ROE is +0.13%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, THCT is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs MKKGY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, MKKGY has a market cap of 59.68B. Regarding current trading prices, THCT is priced at $0.00, while MKKGY trades at $27.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas MKKGY's P/E ratio is 19.24. In terms of profitability, THCT's ROE is +0.13%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, THCT is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs HLNCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HLNCF has a market cap of 46.01B. Regarding current trading prices, THCT is priced at $0.00, while HLNCF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HLNCF's P/E ratio is 24.29. In terms of profitability, THCT's ROE is +0.13%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, THCT is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs TKPHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, TKPHF has a market cap of 41.39B. Regarding current trading prices, THCT is priced at $0.00, while TKPHF trades at $26.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas TKPHF's P/E ratio is 29.22. In terms of profitability, THCT's ROE is +0.13%, compared to TKPHF's ROE of +0.03%. Regarding short-term risk, THCT and TKPHF have similar daily volatility (0.00).
THCT vs IPSEY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, IPSEY has a market cap of 37.69B. Regarding current trading prices, THCT is priced at $0.00, while IPSEY trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas IPSEY's P/E ratio is 23.73. In terms of profitability, THCT's ROE is +0.13%, compared to IPSEY's ROE of +0.17%. Regarding short-term risk, THCT and IPSEY have similar daily volatility (0.00).
THCT vs SDZNY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SDZNY has a market cap of 19.40B. Regarding current trading prices, THCT is priced at $0.00, while SDZNY trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SDZNY's P/E ratio is -2252.25. In terms of profitability, THCT's ROE is +0.13%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, THCT is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs TEVJF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, TEVJF has a market cap of 18.46B. Regarding current trading prices, THCT is priced at $0.00, while TEVJF trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas TEVJF's P/E ratio is -14.01. In terms of profitability, THCT's ROE is +0.13%, compared to TEVJF's ROE of -0.26%. Regarding short-term risk, THCT and TEVJF have similar daily volatility (0.00).
THCT vs ESALY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, ESALY has a market cap of 17.64B. Regarding current trading prices, THCT is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas ESALY's P/E ratio is 20.54. In terms of profitability, THCT's ROE is +0.13%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, THCT is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs SGIOY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SGIOY has a market cap of 14.44B. Regarding current trading prices, THCT is priced at $0.00, while SGIOY trades at $8.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SGIOY's P/E ratio is 12.48. In terms of profitability, THCT's ROE is +0.13%, compared to SGIOY's ROE of +0.08%. Regarding short-term risk, THCT is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs SGIOF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SGIOF has a market cap of 12.93B. Regarding current trading prices, THCT is priced at $0.00, while SGIOF trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SGIOF's P/E ratio is 10.94. In terms of profitability, THCT's ROE is +0.13%, compared to SGIOF's ROE of +0.08%. Regarding short-term risk, THCT and SGIOF have similar daily volatility (0.00).
THCT vs BIOVF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, BIOVF has a market cap of 10.48B. Regarding current trading prices, THCT is priced at $0.00, while BIOVF trades at $30.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas BIOVF's P/E ratio is 26.07. In terms of profitability, THCT's ROE is +0.13%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, THCT is less volatile compared to BIOVF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs IPSEF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, IPSEF has a market cap of 10.37B. Regarding current trading prices, THCT is priced at $0.00, while IPSEF trades at $125.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas IPSEF's P/E ratio is 25.96. In terms of profitability, THCT's ROE is +0.13%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, THCT is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs SFOSF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SFOSF has a market cap of 8.62B. Regarding current trading prices, THCT is priced at $0.00, while SFOSF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SFOSF's P/E ratio is 12.97. In terms of profitability, THCT's ROE is +0.13%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, THCT is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs ESAIY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, ESAIY has a market cap of 7.34B. Regarding current trading prices, THCT is priced at $0.00, while ESAIY trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas ESAIY's P/E ratio is 18.57. In terms of profitability, THCT's ROE is +0.13%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, THCT is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs ESALF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, ESALF has a market cap of 7.34B. Regarding current trading prices, THCT is priced at $0.00, while ESALF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas ESALF's P/E ratio is 18.31. In terms of profitability, THCT's ROE is +0.13%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, THCT and ESALF have similar daily volatility (0.00).
THCT vs GZPHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, GZPHF has a market cap of 6.27B. Regarding current trading prices, THCT is priced at $0.00, while GZPHF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas GZPHF's P/E ratio is 10.61. In terms of profitability, THCT's ROE is +0.13%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, THCT and GZPHF have similar daily volatility (0.00).
THCT vs HKMPF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HKMPF has a market cap of 5.94B. Regarding current trading prices, THCT is priced at $0.00, while HKMPF trades at $26.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HKMPF's P/E ratio is 16.73. In terms of profitability, THCT's ROE is +0.13%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, THCT is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs HKMPY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HKMPY has a market cap of 5.73B. Regarding current trading prices, THCT is priced at $0.00, while HKMPY trades at $51.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HKMPY's P/E ratio is 16.14. In terms of profitability, THCT's ROE is +0.13%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, THCT and HKMPY have similar daily volatility (0.00).
THCT vs APNHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, APNHF has a market cap of 5.44B. Regarding current trading prices, THCT is priced at $0.00, while APNHF trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas APNHF's P/E ratio is 20.07. In terms of profitability, THCT's ROE is +0.13%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, THCT is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs WIBFF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, WIBFF has a market cap of 4.91B. Regarding current trading prices, THCT is priced at $0.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, THCT's ROE is +0.13%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, THCT is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs LVZPF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, LVZPF has a market cap of 4.05B. Regarding current trading prices, THCT is priced at $0.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, THCT's ROE is +0.13%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, THCT is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs HLBBF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HLBBF has a market cap of 4.04B. Regarding current trading prices, THCT is priced at $0.00, while HLBBF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HLBBF's P/E ratio is 10.62. In terms of profitability, THCT's ROE is +0.13%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, THCT is less volatile compared to HLBBF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs HLUBF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HLUBF has a market cap of 3.38B. Regarding current trading prices, THCT is priced at $0.00, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HLUBF's P/E ratio is 7.71. In terms of profitability, THCT's ROE is +0.13%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, THCT is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs APNHY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, APNHY has a market cap of 3.05B. Regarding current trading prices, THCT is priced at $0.00, while APNHY trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas APNHY's P/E ratio is 12.47. In terms of profitability, THCT's ROE is +0.13%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, THCT is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs INVVY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, INVVY has a market cap of 3.01B. Regarding current trading prices, THCT is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas INVVY's P/E ratio is -62.42. In terms of profitability, THCT's ROE is +0.13%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, THCT and INVVY have similar daily volatility (0.00).
THCT vs IZQVF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, IZQVF has a market cap of 2.89B. Regarding current trading prices, THCT is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, THCT's ROE is +0.13%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, THCT and IZQVF have similar daily volatility (0.00).
THCT vs HMDCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HMDCF has a market cap of 2.79B. Regarding current trading prices, THCT is priced at $0.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, THCT's ROE is +0.13%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, THCT is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs HYPMY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HYPMY has a market cap of 2.68B. Regarding current trading prices, THCT is priced at $0.00, while HYPMY trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HYPMY's P/E ratio is 19.28. In terms of profitability, THCT's ROE is +0.13%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, THCT is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs DNPUF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, DNPUF has a market cap of 2.59B. Regarding current trading prices, THCT is priced at $0.00, while DNPUF trades at $6.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas DNPUF's P/E ratio is -2.14. In terms of profitability, THCT's ROE is +0.13%, compared to DNPUF's ROE of -1.05%. Regarding short-term risk, THCT is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs ULIHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, ULIHF has a market cap of 2.54B. Regarding current trading prices, THCT is priced at $0.00, while ULIHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas ULIHF's P/E ratio is 7.00. In terms of profitability, THCT's ROE is +0.13%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, THCT is less volatile compared to ULIHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs HTSUF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HTSUF has a market cap of 2.36B. Regarding current trading prices, THCT is priced at $0.00, while HTSUF trades at $32.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HTSUF's P/E ratio is 15.76. In terms of profitability, THCT's ROE is +0.13%, compared to HTSUF's ROE of +0.05%. Regarding short-term risk, THCT is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs THCBF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, THCBF has a market cap of 2.34B. Regarding current trading prices, THCT is priced at $0.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas THCBF's P/E ratio is -0.10. In terms of profitability, THCT's ROE is +0.13%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, THCT is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CHSYF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CHSYF has a market cap of 2.25B. Regarding current trading prices, THCT is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CHSYF's P/E ratio is 6.65. In terms of profitability, THCT's ROE is +0.13%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, THCT and CHSYF have similar daily volatility (0.00).
THCT vs TSMRF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, TSMRF has a market cap of 2.13B. Regarding current trading prices, THCT is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas TSMRF's P/E ratio is 13.03. In terms of profitability, THCT's ROE is +0.13%, compared to TSMRF's ROE of +0.07%. Regarding short-term risk, THCT and TSMRF have similar daily volatility (0.00).
THCT vs DMPHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, DMPHF has a market cap of 2.13B. Regarding current trading prices, THCT is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas DMPHF's P/E ratio is 16.69. In terms of profitability, THCT's ROE is +0.13%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, THCT and DMPHF have similar daily volatility (0.00).
THCT vs LJUIF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, LJUIF has a market cap of 2.06B. Regarding current trading prices, THCT is priced at $0.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, THCT's ROE is +0.13%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, THCT and LJUIF have similar daily volatility (0.00).
THCT vs LBTSF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, LBTSF has a market cap of 1.92B. Regarding current trading prices, THCT is priced at $0.00, while LBTSF trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas LBTSF's P/E ratio is 150.17. In terms of profitability, THCT's ROE is +0.13%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, THCT is less volatile compared to LBTSF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs NPNKF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, NPNKF has a market cap of 1.77B. Regarding current trading prices, THCT is priced at $0.00, while NPNKF trades at $26.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas NPNKF's P/E ratio is 8.35. In terms of profitability, THCT's ROE is +0.13%, compared to NPNKF's ROE of +0.09%. Regarding short-term risk, THCT is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs SHEZF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SHEZF has a market cap of 1.69B. Regarding current trading prices, THCT is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, THCT's ROE is +0.13%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, THCT is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CHIZF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CHIZF has a market cap of 1.69B. Regarding current trading prices, THCT is priced at $0.00, while CHIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CHIZF's P/E ratio is 16.80. In terms of profitability, THCT's ROE is +0.13%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, THCT and CHIZF have similar daily volatility (0.00).
THCT vs SMDPY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SMDPY has a market cap of 1.63B. Regarding current trading prices, THCT is priced at $0.00, while SMDPY trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SMDPY's P/E ratio is -1.32. In terms of profitability, THCT's ROE is +0.13%, compared to SMDPY's ROE of -1.44%. Regarding short-term risk, THCT and SMDPY have similar daily volatility (0.00).
THCT vs AUSAF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, AUSAF has a market cap of 1.57B. Regarding current trading prices, THCT is priced at $0.00, while AUSAF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas AUSAF's P/E ratio is N/A. In terms of profitability, THCT's ROE is +0.13%, compared to AUSAF's ROE of -1.15%. Regarding short-term risk, THCT is less volatile compared to AUSAF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs NPPNY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, NPPNY has a market cap of 1.57B. Regarding current trading prices, THCT is priced at $0.00, while NPPNY trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas NPPNY's P/E ratio is 7.35. In terms of profitability, THCT's ROE is +0.13%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, THCT is less volatile compared to NPPNY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs KARBF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, KARBF has a market cap of 1.52B. Regarding current trading prices, THCT is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas KARBF's P/E ratio is 262.50. In terms of profitability, THCT's ROE is +0.13%, compared to KARBF's ROE of N/A. Regarding short-term risk, THCT and KARBF have similar daily volatility (0.00).
THCT vs YIHCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, YIHCF has a market cap of 1.48B. Regarding current trading prices, THCT is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, THCT's ROE is +0.13%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, THCT and YIHCF have similar daily volatility (0.00).
THCT vs EVOTF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, EVOTF has a market cap of 1.47B. Regarding current trading prices, THCT is priced at $0.00, while EVOTF trades at $8.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas EVOTF's P/E ratio is -7.52. In terms of profitability, THCT's ROE is +0.13%, compared to EVOTF's ROE of -0.19%. Regarding short-term risk, THCT is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs ARSUF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, ARSUF has a market cap of 1.46B. Regarding current trading prices, THCT is priced at $0.00, while ARSUF trades at $20.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas ARSUF's P/E ratio is 18.05. In terms of profitability, THCT's ROE is +0.13%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, THCT is less volatile compared to ARSUF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs GTBIF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, GTBIF has a market cap of 1.30B. Regarding current trading prices, THCT is priced at $0.00, while GTBIF trades at $5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas GTBIF's P/E ratio is 26.10. In terms of profitability, THCT's ROE is +0.13%, compared to GTBIF's ROE of +0.04%. Regarding short-term risk, THCT is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs SWGHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SWGHF has a market cap of 1.15B. Regarding current trading prices, THCT is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SWGHF's P/E ratio is 13.88. In terms of profitability, THCT's ROE is +0.13%, compared to SWGHF's ROE of +0.10%. Regarding short-term risk, THCT and SWGHF have similar daily volatility (0.00).
THCT vs BIOGY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, BIOGY has a market cap of 1.12B. Regarding current trading prices, THCT is priced at $0.00, while BIOGY trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas BIOGY's P/E ratio is 33.78. In terms of profitability, THCT's ROE is +0.13%, compared to BIOGY's ROE of +0.20%. Regarding short-term risk, THCT is less volatile compared to BIOGY. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs GNMLF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, GNMLF has a market cap of 1.09B. Regarding current trading prices, THCT is priced at $0.00, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas GNMLF's P/E ratio is 9.91. In terms of profitability, THCT's ROE is +0.13%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, THCT and GNMLF have similar daily volatility (0.00).
THCT vs NIKA Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, NIKA has a market cap of 1.03B. Regarding current trading prices, THCT is priced at $0.00, while NIKA trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas NIKA's P/E ratio is N/A. In terms of profitability, THCT's ROE is +0.13%, compared to NIKA's ROE of +0.63%. Regarding short-term risk, THCT and NIKA have similar daily volatility (0.00).
THCT vs KKPCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, KKPCF has a market cap of 1.01B. Regarding current trading prices, THCT is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas KKPCF's P/E ratio is 7.10. In terms of profitability, THCT's ROE is +0.13%, compared to KKPCF's ROE of +0.04%. Regarding short-term risk, THCT is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs KSPHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, KSPHF has a market cap of 994.32M. Regarding current trading prices, THCT is priced at $0.00, while KSPHF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas KSPHF's P/E ratio is 12.16. In terms of profitability, THCT's ROE is +0.13%, compared to KSPHF's ROE of +0.05%. Regarding short-term risk, THCT is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CASBF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CASBF has a market cap of 984.67M. Regarding current trading prices, THCT is priced at $0.00, while CASBF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CASBF's P/E ratio is -15.24. In terms of profitability, THCT's ROE is +0.13%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, THCT is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs LVTTF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, LVTTF has a market cap of 877.56M. Regarding current trading prices, THCT is priced at $0.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, THCT's ROE is +0.13%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, THCT is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs EVRRF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, EVRRF has a market cap of 873.78M. Regarding current trading prices, THCT is priced at $0.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, THCT's ROE is +0.13%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, THCT and EVRRF have similar daily volatility (0.00).
THCT vs TCNNF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, TCNNF has a market cap of 857.94M. Regarding current trading prices, THCT is priced at $0.00, while TCNNF trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas TCNNF's P/E ratio is -5.68. In terms of profitability, THCT's ROE is +0.13%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, THCT is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs NRXCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, NRXCF has a market cap of 829.09M. Regarding current trading prices, THCT is priced at $0.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, THCT's ROE is +0.13%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, THCT and NRXCF have similar daily volatility (0.00).
THCT vs TWAPF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, TWAPF has a market cap of 828.49M. Regarding current trading prices, THCT is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas TWAPF's P/E ratio is 6.16. In terms of profitability, THCT's ROE is +0.13%, compared to TWAPF's ROE of +0.09%. Regarding short-term risk, THCT and TWAPF have similar daily volatility (0.00).
THCT vs CSWYF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CSWYF has a market cap of 815.83M. Regarding current trading prices, THCT is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, THCT's ROE is +0.13%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, THCT is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs TRXPF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, TRXPF has a market cap of 690.69M. Regarding current trading prices, THCT is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, THCT's ROE is +0.13%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, THCT and TRXPF have similar daily volatility (0.00).
THCT vs SWDCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SWDCF has a market cap of 679.32M. Regarding current trading prices, THCT is priced at $0.00, while SWDCF trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SWDCF's P/E ratio is 70.83. In terms of profitability, THCT's ROE is +0.13%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, THCT is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CURLF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CURLF has a market cap of 659.31M. Regarding current trading prices, THCT is priced at $0.00, while CURLF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CURLF's P/E ratio is -2.65. In terms of profitability, THCT's ROE is +0.13%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, THCT is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs TRSSF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, TRSSF has a market cap of 601.91M. Regarding current trading prices, THCT is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, THCT's ROE is +0.13%, compared to TRSSF's ROE of -0.43%. Regarding short-term risk, THCT is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs SGFEF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SGFEF has a market cap of 544.13M. Regarding current trading prices, THCT is priced at $0.00, while SGFEF trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SGFEF's P/E ratio is 22.83. In terms of profitability, THCT's ROE is +0.13%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, THCT is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CCHWF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CCHWF has a market cap of 521.35M. Regarding current trading prices, THCT is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, THCT's ROE is +0.13%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, THCT is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs AIHLF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, AIHLF has a market cap of 507.80M. Regarding current trading prices, THCT is priced at $0.00, while AIHLF trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas AIHLF's P/E ratio is 10.83. In terms of profitability, THCT's ROE is +0.13%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, THCT is less volatile compared to AIHLF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs BOIRF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, BOIRF has a market cap of 494.82M. Regarding current trading prices, THCT is priced at $0.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, THCT's ROE is +0.13%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, THCT is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs ELTP Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, ELTP has a market cap of 471.11M. Regarding current trading prices, THCT is priced at $0.00, while ELTP trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas ELTP's P/E ratio is -22.05. In terms of profitability, THCT's ROE is +0.13%, compared to ELTP's ROE of -0.36%. Regarding short-term risk, THCT is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs PEXXF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, PEXXF has a market cap of 463.12M. Regarding current trading prices, THCT is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, THCT's ROE is +0.13%, compared to PEXXF's ROE of N/A. Regarding short-term risk, THCT and PEXXF have similar daily volatility (0.00).
THCT vs GLASF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, GLASF has a market cap of 460.08M. Regarding current trading prices, THCT is priced at $0.00, while GLASF trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas GLASF's P/E ratio is -31.12. In terms of profitability, THCT's ROE is +0.13%, compared to GLASF's ROE of +0.00%. Regarding short-term risk, THCT is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs SHPHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, SHPHF has a market cap of 455.30M. Regarding current trading prices, THCT is priced at $0.00, while SHPHF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas SHPHF's P/E ratio is -1.64. In terms of profitability, THCT's ROE is +0.13%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, THCT is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs MITPF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, MITPF has a market cap of 451.63M. Regarding current trading prices, THCT is priced at $0.00, while MITPF trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas MITPF's P/E ratio is -3.05. In terms of profitability, THCT's ROE is +0.13%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, THCT and MITPF have similar daily volatility (0.00).
THCT vs KHTRF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, KHTRF has a market cap of 443.54M. Regarding current trading prices, THCT is priced at $0.00, while KHTRF trades at $4.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas KHTRF's P/E ratio is 148.67. In terms of profitability, THCT's ROE is +0.13%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, THCT is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs AGYTF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, AGYTF has a market cap of 405.15M. Regarding current trading prices, THCT is priced at $0.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, THCT's ROE is +0.13%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, THCT is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs PKBFF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, PKBFF has a market cap of 285.89M. Regarding current trading prices, THCT is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas PKBFF's P/E ratio is -0.00. In terms of profitability, THCT's ROE is +0.13%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, THCT is less volatile compared to PKBFF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs BHCCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, BHCCF has a market cap of 271.24M. Regarding current trading prices, THCT is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, THCT's ROE is +0.13%, compared to BHCCF's ROE of -0.18%. Regarding short-term risk, THCT is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs VRNOF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, VRNOF has a market cap of 255.40M. Regarding current trading prices, THCT is priced at $0.00, while VRNOF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas VRNOF's P/E ratio is -0.71. In terms of profitability, THCT's ROE is +0.13%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, THCT is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CRLBF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CRLBF has a market cap of 236.39M. Regarding current trading prices, THCT is priced at $0.00, while CRLBF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CRLBF's P/E ratio is -3.19. In terms of profitability, THCT's ROE is +0.13%, compared to CRLBF's ROE of -0.16%. Regarding short-term risk, THCT is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CPHRF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CPHRF has a market cap of 228.23M. Regarding current trading prices, THCT is priced at $0.00, while CPHRF trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CPHRF's P/E ratio is 24.75. In terms of profitability, THCT's ROE is +0.13%, compared to CPHRF's ROE of +0.12%. Regarding short-term risk, THCT is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs PLNHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, PLNHF has a market cap of 202.02M. Regarding current trading prices, THCT is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, THCT's ROE is +0.13%, compared to PLNHF's ROE of +0.01%. Regarding short-term risk, THCT is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs HUMDF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HUMDF has a market cap of 147.55M. Regarding current trading prices, THCT is priced at $0.00, while HUMDF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HUMDF's P/E ratio is -3.75. In terms of profitability, THCT's ROE is +0.13%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, THCT and HUMDF have similar daily volatility (0.00).
THCT vs COPHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, COPHF has a market cap of 131.72M. Regarding current trading prices, THCT is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas COPHF's P/E ratio is -0.02. In terms of profitability, THCT's ROE is +0.13%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, THCT is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs PHCUF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, PHCUF has a market cap of 117.10M. Regarding current trading prices, THCT is priced at $0.00, while PHCUF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas PHCUF's P/E ratio is -432.00. In terms of profitability, THCT's ROE is +0.13%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, THCT is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs LPCUF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, LPCUF has a market cap of 110.82M. Regarding current trading prices, THCT is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, THCT's ROE is +0.13%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, THCT and LPCUF have similar daily volatility (0.00).
THCT vs CNVCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CNVCF has a market cap of 109.16M. Regarding current trading prices, THCT is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, THCT's ROE is +0.13%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, THCT and CNVCF have similar daily volatility (0.00).
THCT vs HLTRF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, HLTRF has a market cap of 102.37M. Regarding current trading prices, THCT is priced at $0.00, while HLTRF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas HLTRF's P/E ratio is -5.19. In terms of profitability, THCT's ROE is +0.13%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, THCT is less volatile compared to HLTRF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs GRUSF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, GRUSF has a market cap of 97.16M. Regarding current trading prices, THCT is priced at $0.00, while GRUSF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas GRUSF's P/E ratio is -7.84. In terms of profitability, THCT's ROE is +0.13%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, THCT is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs ABSCF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, ABSCF has a market cap of 92.53M. Regarding current trading prices, THCT is priced at $0.00, while ABSCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas ABSCF's P/E ratio is -20.00. In terms of profitability, THCT's ROE is +0.13%, compared to ABSCF's ROE of +0.26%. Regarding short-term risk, THCT is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs PLNH Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, PLNH has a market cap of 88.47M. Regarding current trading prices, THCT is priced at $0.00, while PLNH trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas PLNH's P/E ratio is -1.70. In terms of profitability, THCT's ROE is +0.13%, compared to PLNH's ROE of -0.36%. Regarding short-term risk, THCT is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs BIOYF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, BIOYF has a market cap of 88.33M. Regarding current trading prices, THCT is priced at $0.00, while BIOYF trades at $7.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas BIOYF's P/E ratio is 17.11. In terms of profitability, THCT's ROE is +0.13%, compared to BIOYF's ROE of +0.20%. Regarding short-term risk, THCT is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs CBWTF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, CBWTF has a market cap of 86.66M. Regarding current trading prices, THCT is priced at $0.00, while CBWTF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas CBWTF's P/E ratio is -6.60. In terms of profitability, THCT's ROE is +0.13%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, THCT is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs LOVFF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, LOVFF has a market cap of 84.71M. Regarding current trading prices, THCT is priced at $0.00, while LOVFF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas LOVFF's P/E ratio is 9.34. In terms of profitability, THCT's ROE is +0.13%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, THCT is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs GBLP Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, GBLP has a market cap of 83.54M. Regarding current trading prices, THCT is priced at $0.00, while GBLP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas GBLP's P/E ratio is -0.67. In terms of profitability, THCT's ROE is +0.13%, compared to GBLP's ROE of +0.31%. Regarding short-term risk, THCT is less volatile compared to GBLP. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs LRDSF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, LRDSF has a market cap of 82.83M. Regarding current trading prices, THCT is priced at $0.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, THCT's ROE is +0.13%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, THCT is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs EOFBY Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, EOFBY has a market cap of 73.67M. Regarding current trading prices, THCT is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, THCT's ROE is +0.13%, compared to EOFBY's ROE of N/A. Regarding short-term risk, THCT and EOFBY have similar daily volatility (0.00).
THCT vs AAWH Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, AAWH has a market cap of 67.87M. Regarding current trading prices, THCT is priced at $0.00, while AAWH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas AAWH's P/E ratio is -0.83. In terms of profitability, THCT's ROE is +0.13%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, THCT is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.
THCT vs JUSHF Comparison
THCT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, THCT stands at 12068.00. In comparison, JUSHF has a market cap of 62.94M. Regarding current trading prices, THCT is priced at $0.00, while JUSHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
THCT currently has a P/E ratio of -0.01, whereas JUSHF's P/E ratio is -1.28. In terms of profitability, THCT's ROE is +0.13%, compared to JUSHF's ROE of +1.44%. Regarding short-term risk, THCT is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for THCT.